chr12-63984040-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_020762.4(SRGAP1):c.161G>A(p.Arg54Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000448 in 1,562,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 28)
Exomes 𝑓: 0.0000042 ( 0 hom. )
Consequence
SRGAP1
NM_020762.4 missense
NM_020762.4 missense
Scores
8
7
4
Clinical Significance
Conservation
PhyloP100: 9.92
Genes affected
SRGAP1 (HGNC:17382): (SLIT-ROBO Rho GTPase activating protein 1) The protein encoded by this gene is a GTPase activator, working with the GTPase CDC42 to negatively regulate neuronal migration. The encoded protein interacts with the transmembrane receptor ROBO1 to inactivate CDC42. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.796
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRGAP1 | NM_020762.4 | c.161G>A | p.Arg54Gln | missense_variant | 2/22 | ENST00000355086.8 | NP_065813.1 | |
SRGAP1 | NM_001346201.2 | c.161G>A | p.Arg54Gln | missense_variant | 2/22 | NP_001333130.1 | ||
SRGAP1 | XM_024449096.2 | c.161G>A | p.Arg54Gln | missense_variant | 2/14 | XP_024304864.1 | ||
SRGAP1 | XM_024449097.2 | c.161G>A | p.Arg54Gln | missense_variant | 2/12 | XP_024304865.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRGAP1 | ENST00000355086.8 | c.161G>A | p.Arg54Gln | missense_variant | 2/22 | 1 | NM_020762.4 | ENSP00000347198.3 |
Frequencies
GnomAD3 genomes AF: 0.00000662 AC: 1AN: 151046Hom.: 0 Cov.: 28
GnomAD3 genomes
AF:
AC:
1
AN:
151046
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000427 AC: 1AN: 233944Hom.: 0 AF XY: 0.00000787 AC XY: 1AN XY: 127142
GnomAD3 exomes
AF:
AC:
1
AN:
233944
Hom.:
AF XY:
AC XY:
1
AN XY:
127142
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000425 AC: 6AN: 1411950Hom.: 0 Cov.: 30 AF XY: 0.00000569 AC XY: 4AN XY: 702520
GnomAD4 exome
AF:
AC:
6
AN:
1411950
Hom.:
Cov.:
30
AF XY:
AC XY:
4
AN XY:
702520
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000662 AC: 1AN: 151046Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 73664
GnomAD4 genome
AF:
AC:
1
AN:
151046
Hom.:
Cov.:
28
AF XY:
AC XY:
0
AN XY:
73664
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SRGAP1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 23, 2023 | The SRGAP1 c.161G>A variant is predicted to result in the amino acid substitution p.Arg54Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.00093% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/12-64377820-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;.
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;D
REVEL
Uncertain
Sift
Pathogenic
D;.;D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;D
Vest4
MutPred
Gain of ubiquitination at K56 (P = 0.0443);.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at